Disposable Syringes Global Market Report 2024

The disposable syringes market size has grown strongly in recent years. It will grow from $11.44 billion in 2023 to $12.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The expansion observed in the historical period can be ascribed to factors such as the HIV/AIDS epidemic, the implementation of enhanced vaccination programs, the growth of the biotechnology and pharmaceutical industries, the prevalence of chronic diseases, and the overall increase in the global population.

The disposable syringes market size is expected to see strong growth in the next few years. It will grow to $15.74 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to an increased awareness of bloodborne infections, a heightened focus on patient safety, the integration of digital health technologies, regulatory emphasis on single-use devices, and global health initiatives. Major trends in the forecast period encompass advancements in injection technologies, technological innovations in material sciences, a focus on sustainable healthcare, innovations in needle safety, and the incorporation of 3D printing in syringe manufacturing.

The anticipated growth of the disposable syringes market is expected to be driven by the rising incidences of chronic diseases. Chronic diseases, which last three months or more and can worsen over time, include conditions such as diabetes. Disposable syringes, widely used for various chronic diseases, particularly in the treatment of diabetes patients, offer a safer method of drug administration. For example, a report from January 2023 by the National Library of Medicine, a US-based agency, projects a 99.5% increase in the number of people aged 50 and older with at least one chronic condition in the US, rising from 71.522 million in 2020 to 142.66 million by 2050. Hence, the growing incidences of chronic diseases are a key driver for the disposable syringes market.

The growth of the disposable syringes market is expected to be fueled by the increasing use of injectable drugs. Injectable drugs, administered directly into the bloodstream using syringes and needles, are employed in treating various diseases, including chronic conditions such as diabetes, hypertension, and cancer. Disposable syringes play a vital role in the administration of injectable drugs, ensuring the safe and efficient delivery of medications such as vaccines, insulin, and other injectable pharmaceuticals. As per a 2023 report from the United Nations Office on Drugs and Crime (UNODC), an estimated 13.2 million people globally were injecting drugs in 2021, representing a 1% increase from 2020 (11.2 million). Consequently, the increasing use of injectable drugs is a significant factor driving the growth of the disposable syringes market.


Product innovation stands out as a key trend gaining traction in the disposable syringe market, with major companies actively pursuing innovative solutions to maintain their market positions. An example of this trend is evident in the actions of Becton Dickinson and Company, a US-based medical device company, which introduced the BD Intevia 1 mL two-step disposable autoinjector in September 2021. This platform device seamlessly combines a pre-fillable syringe with an autoinjector, creating an integrated system that allows for the safe and effective injection of drugs with varying fill volumes up to 1 mL and viscosities up to 35 cP. The unique design of the BD Intevia 1 mL enables its adoption for a diverse range of drugs by pharmaceutical companies.

Major players in the disposable syringe market are strategically engaging in partnerships to incorporate new technologies, thereby gaining a competitive edge. A notable instance of this strategic approach is the collaboration between BP PLC, a US-based medical technology company, and Mitsubishi Gas Chemical Company, a Japan-based chemical company. This partnership, initiated in May 2022, aims to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced biologic pharmaceuticals. Oxycapt technology, with its multilayer structure, is designed to offer features such as excellent breaking resistance, low protein adsorption, strong UV barrier, pH stability, and effective oxygen and vapor barrier on silicon-free plastic syringe barrels. The collaboration intends to explore practical solutions for delivering newer biologic compounds, focusing on advancing sustainability and reducing carbon footprints.

In January 2022, ICU Medical Inc., a US-based medical device company, acquired Smiths Medical from Smiths Group plc in an undisclosed deal. This acquisition positions ICU Medical to enhance its corporate culture, emphasizing value creation through accountability, informed decision-making, transparency, and customer-centric focus. Smiths Medical, the acquired company, specializes in manufacturing disposable syringes for therapeutic, diagnostic, and surgical procedures, contributing to ICU Medical's comprehensive portfolio in the medical device industry.

Major companies operating in the disposable syringes market report are Nipro Corporation, Cardinal Health Inc., Fresenius Kabi AG, Medtronic PLC, Novo Nordisk AS, Becton Dickinson & Company Ltd., Baxter Pharmaceutical Solutions LLC, B. Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Gerresheimer AG, Pisa Pharmaceuticals Company, Shanghai Kindly Enterprise Development Group Co. Ltd., Jiangxi Sanxin Medtec Co.Ltd., Henke Sass Wolf Medical Instruments (Qingdao) Ltd., Retractable Technologies Inc., CODAN Medizinische Geräte GmbH & Co KG, UltiMed Inc., Sol-Millennium Medical Inc., Unilife Corporation, Vita Needle Company, Jiangsu Jichun Medical Devices Co. Ltd., Exelint International Co., ISCON Surgicals Ltd., Shanghai Kohope Medical Co Ltd., Star Syringe Ltd., Injex Industrias Cirurgicas Ltda, Feel Tech Bio Co. Ltd., Hindustan Syringes & Medical Devices Ltd., Liaoning Kangyi Medical Equipment Co. Ltd.

North America was the largest region in the disposable syringes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disposable syringes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disposable syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of disposable syringes include conventional syringes and safety syringes. Conventional disposable syringes are traditional small hollow tubes employed for injecting or withdrawing liquids. They involve attaching a needle to draw fluids from the body or administer drugs into the body. These syringes find applications in various scenarios such as immunization injections and therapeutic injections. They are utilized by a range of end users, including hospitals, diagnostic laboratories, blood banks, and the pharmaceutical industry.

The disposable syringes market research report is one of a series of new reports that provides Disposable syringes market statistics, including disposable syringes industry global market size, regional shares, competitors with a disposable syringes market share, detailed disposable syringes market segments, market trends, and opportunities, and any further data you may need to thrive in the disposable syringes industry. This disposable syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The disposable syringes market consists of sales of luer lock syringes, luer slip syringes, and catheter tip syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.